1W Return
1M Return
6M Return
1Y Return
3Y Return
Open
Prev. Close
Total Traded Value
Market Cap (in crs)
Face Value
Turnover (in lacs)
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
73.29 Cr | 77.38 Cr | 65.62 Cr | 59.83 Cr | 60.78 Cr |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
238.65 Cr | 339.07 Cr | 284.36 Cr | 233.56 Cr | 48.44 Cr |
Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
5.36 Cr | 4.59 Cr | 6.48 Cr | 10.93 Cr | 13.59 Cr |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
-2.39 Cr | 45.96 Cr | 47.66 Cr | 38.14 Cr | 6.1 Cr |
Balaxi Pharmaceuticals Ltd reported a 5.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 27.3%.
Its expenses for the quarter were up by 5.1% QoQ and 48.2% YoY.
The net profit increased 16.8% QoQ and decreased 60.6% YoY.
The earnings per share (EPS) of Balaxi Pharmaceuticals Ltd stood at 1 during Q3FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 8471 Rs | 15819 Rs |
Week Rs | 19372 Rs | 30788 Rs |
Month Rs | 18117 Rs | 35635 Rs |
Company | Market Price | Market Cap | 52W Low | 52W High |
---|---|---|---|---|
Ambalal Sarabhai Enterprises Ltd. | - | - | - | |
Coral Laboratories Ltd. | - | - | - | |
Oxygenta Pharmaceutical Ltd. | - | - | - | |
Gennex Laboratories Ltd. | - | - | - | |
Fredun Pharmaceuticals Ltd. | - | - | - | |
Infinium Pharmachem Ltd. | - | - | - |
Balaxi Pharmaceuticals Ltd share price in the past 1-year return was -54.2. The Balaxi Pharmaceuticals Ltd share hit a 1-year low of Rs. 51 and a 1-year high of Rs. 151.45.
The market cap of Balaxi Pharmaceuticals Ltd is Rs. 312.92 Cr. as of 21/2/2025 12:00:00 AM.
The PE ratios of Balaxi Pharmaceuticals Ltd is 74.58 as of 21/2/2025 12:00:00 AM.
The PB ratios of Balaxi Pharmaceuticals Ltd is 2.45 as of 21/2/2025 12:00:00 AM
You can easily buy Balaxi Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.